Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.
Fiche publication
Date publication
janvier 2021
Journal
Therapeutic advances in gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Garcia KS, Facas BP, Machado MB, Teixeira FV, Avedano L, Lönnfors S, Hossne RS, Peyrin-Biroulet L, Queiroz NSF
Lien Pubmed
Résumé
In this analysis we aimed to describe Brazilian inflammatory bowel disease (IBD) patients' knowledge and perceptions regarding biosimilars and compare with viewpoints from non-Brazilian patients.
Mots clés
adalimumab, biosimilar, inflammatory bowel disease, infliximab
Référence
Therap Adv Gastroenterol. 2021 ;14:17562848211013249